97 related articles for article (PubMed ID: 23036067)
1. The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.
Ypma PF; Kerkhoffs JL; van Hilten JA; Middelburg RA; Coccoris M; Zwaginga JJ; Beckers EM; Fijnheer R; van der Meer PF; Brand A
Transfus Med; 2012 Dec; 22(6):426-31. PubMed ID: 23036067
[TBL] [Abstract][Full Text] [Related]
2. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
3. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.
Webert K; Cook RJ; Sigouin CS; Rebulla P; Heddle NM
Haematologica; 2006 Nov; 91(11):1530-7. PubMed ID: 17043016
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
Stanworth SJ; Dyer C; Casbard A; Murphy MF
Vox Sang; 2006 Jul; 91(1):63-9. PubMed ID: 16756603
[TBL] [Abstract][Full Text] [Related]
5. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.
Stanworth SJ; Hudson CL; Estcourt LJ; Johnson RJ; Wood EM;
Haematologica; 2015 Jun; 100(6):740-7. PubMed ID: 25795717
[TBL] [Abstract][Full Text] [Related]
6. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
[TBL] [Abstract][Full Text] [Related]
7. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
[TBL] [Abstract][Full Text] [Related]
8. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
[TBL] [Abstract][Full Text] [Related]
9. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
10. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
[TBL] [Abstract][Full Text] [Related]
11. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
12. The influence of bleeding on trigger changes for platelet transfusion in patients with chemotherapy-induced thrombocytopenia.
Rioux-Massé B; Laroche V; Bowman RJ; Lindgren BR; Cohn CS; Pulkrabek SM; McCullough J
Transfusion; 2013 Feb; 53(2):306-14. PubMed ID: 22670810
[TBL] [Abstract][Full Text] [Related]
13. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
14. Thrombelastography monitoring of platelet substitution therapy and rFVIIa administration in haemato-oncological patients with severe thrombocytopenia.
Salaj P; Marinov I; Marková M; Pohlreich D; Cetkovský P; Hrachovinová I
Prague Med Rep; 2004; 105(3):311-7. PubMed ID: 15782557
[TBL] [Abstract][Full Text] [Related]
15. The clinical impact of platelet refractoriness: correlation with bleeding and survival.
Kerkhoffs JL; Eikenboom JC; van de Watering LM; van Wordragen-Vlaswinkel RJ; Wijermans PW; Brand A
Transfusion; 2008 Sep; 48(9):1959-65. PubMed ID: 18564396
[TBL] [Abstract][Full Text] [Related]
16. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
Zeidler K; Arn K; Senn O; Schanz U; Stussi G
Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
[TBL] [Abstract][Full Text] [Related]
17. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
18. Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates.
Hoque MM; Rahman M; Rahman SM; Habibullah MM; Faruki MA; Rahman KH; Mamun AA; Hossain MA
Mymensingh Med J; 2013 Jan; 22(1):64-8. PubMed ID: 23416811
[TBL] [Abstract][Full Text] [Related]
19. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
20. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]